Clicky

Edwards Lifesciences Corporation(EW)

Description: Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products, which are used to replace or repair a patient's diseased or defective heart valve; and produces pericardial and porcine valves. Its surgical heart valve therapy products include Carpentier-Edwards PERIMOUNT pericardial valve that comprise PERIMOUNT Magna Ease valves for aortic and mitral replacement; ThruPort systems that enable minimal incision valve surgery; and protection cannulae used during cardiac surgery in venous drainage, aortic perfusion, venting, and cardioplegia delivery. The company also provides transcatheter heart valves portfolio that includes technologies designed to treat heart valve disease using catheter-based approaches, as well as critical care products, such as hemodynamic monitoring systems to measure a patient's heart function in surgical and intensive care settings; Swan-Ganz line of pulmonary artery catheters and PreSep continuous venous oximetry catheters for measuring central venous oxygen saturation; VolumeView sensor-catheters; FloTrac continuous cardiac output monitoring system, a minimally invasive cardiac monitoring technology for goal-directed fluid optimization; and EV1000 clinical monitoring platform, which displays a patient's physiologic status. Its critical care products also include disposable pressure monitoring devices and closed blood sampling systems to help protect both patients and clinicians from the risk of infection; and products used to treat endolumenal occlusive disease, including balloon-tipped, catheter-based embolectomy products, surgical clips, and clamps. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.


Keywords: Medicine S&P 500 Clinical Medicine Surgery Infection Catheter Care Products Heart Oxygen Port Drainage Heart Disease Cardiac Surgery Artery Incision Perfusion Cannula Heart Valve Edwards Repair Products Cardiac Monitoring Valvular Heart Disease Cardiac Output Embolectomy Edwards Lifesciences Heart Valve Disease Structural Heart Disease

Home Page: www.edwards.com

EW Technical Analysis

One Edwards Way
Irvine, CA 92614
United States
Phone: 949 250 2500


Officers

Name Title
Mr. Michael A. Mussallem Chairman & CEO
Mr. Scott B. Ullem Corp. VP & CFO
Mr. Donald E. Bobo Jr. Corp. VP of Strategy & Corp. Devel.
Mr. Larry L. Wood Corp. VP of Transcatheter Aortic Valve Replacement
Mr. Jean-Luc Lemercier Corp. VP of Europe, Middle East, Africa, Canada & Latin America
Dr. Todd J. Brinton Corp. VP of Advanced Technology & Chief Scientific Officer
Mark Wilterding VP of Investor Relations
Mr. Arnold A. Pinkston Corp. VP & Gen. Counsel
Mr. Dirksen J. Lehman Corp. VP of Public Affairs
Ms. Christine Z. McCauley Corp. VP of HR

Exchange: NYSE

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 30.1205
Trailing PE: 33.3406
Price-to-Book MRQ: 7.5391
Price-to-Sales TTM: 8.4778
IPO Date: 2000-03-27
Fiscal Year End: December
Full Time Employees: 15700
Back to stocks